Market Overview

US Stock Futures Edge Lower Ahead Of Wholesale Inventories Data

US Stock Futures Edge Lower Ahead Of Wholesale Inventories Data

Pre-open movers

US stock futures traded slightly lower in early pre-market trade. Data on wholesale inventories for April will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average dipped 13.50 points to 17,754.50, while the Standard & Poor's 500 index futures fell 1.60 points to 2,076.65. Futures for the Nasdaq 100 index dropped 9.55 points to 4,422.70.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index declining 0.49 percent, STOXX Europe 600 Index dipping 0.60 percent and German DAX 30 index dropping 1.18 percent. French CAC 40 Index slipped 0.46 percent and London's FTSE 100 Index fell 0.18 percent.

In Asian markets, Japan's Nikkei Stock Average fell 1.76 percent, China's Shanghai Composite Index slipped 0.36 percent, Hong Kong's Hang Seng Index declined 1.20 percent and India's BSE Sensex fell 0.16 percent.

Broker Recommendation
Analysts at Deutsche Bank upgraded Amedisys Inc (NASDAQ: AMED) from Hold to Buy and raised the price target from $28.00 to $41.00.

Amedisys shares rose 1.46 percent to close at $34.64 yesterday.

Breaking news

  • HD Supply Holdings Inc (NASDAQ: HDS) reported stronger-than-expected earnings for the first quarter. To read the full news, click here.
  • Mechel ОАО (NYSE: MTL), one of the leading Russian mining and metals companies, announces signing a memorandum with China's Jidong Cement, one of the world's top ten cement producers. To read the full news, click here.
  • Lululemon Athletica inc. (NASDAQ: LULU) reported better-than-expected results for the first quarter and lifted its full-year outlook. To read the full news, click here.
  • RedHill Biopharma Ltd. (NASDAQ: RDHL) today announced that the last patient has been enrolled in the Phase IIa, proof-of-concept clinical study evaluating RHB-104 as an add-on therapy to interferon beta-1a in patients treated for relapsing remitting multiple sclerosis (RRMS). To read the full news, click here.

Related Articles (AMED + HDS)

View Comments and Join the Discussion!

Posted-In: Deutsche Bank US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets